Cannabinoid protects injured brain

No effective drug currently exists to treat brain injury and the mechanisms that control post-trauma events remain largely unknown. In October 4 Nature, David Panikashvili and colleagues from the Hebrew University, Jerusalem, show that the cannabinoid, 2-arachidonoyl glycerol (2-AG) is part of an endogenous system that protects the brain in the period following traumatic injury.Panikashvili et al. observed that after closed head injury in mice the level of endogenous 2-AG was significantly eleva

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

No effective drug currently exists to treat brain injury and the mechanisms that control post-trauma events remain largely unknown. In October 4 Nature, David Panikashvili and colleagues from the Hebrew University, Jerusalem, show that the cannabinoid, 2-arachidonoyl glycerol (2-AG) is part of an endogenous system that protects the brain in the period following traumatic injury.

Panikashvili et al. observed that after closed head injury in mice the level of endogenous 2-AG was significantly elevated. Consequently they administered synthetic 2-AG to mice following head injury and found a significant reduction in brain edema, a better clinical recovery, reduced infarct volume and reduced hippocampal cell death compared with control animals. This recovery was further enhanced by additional administration of inactive 2-acyl-glycerols and was dose-dependently attenuated by SR-141761A, an antagonist of the CB1 cannabinoid receptor (Nature, 2001, 413:527-531).

They suggest that this interaction leads to 2-AG suppression of the formation of reactive oxygen ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution